Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line

Fri, 20th Mar 2020 10:49

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

InterContinental Hotels Group, up 11%. The Holiday Inn and Crowne Plaza owner said demand is currently at the lowest level it has ever seen. To combat this, IHG is hoping to save about USD150 million through salary cuts, including "substantial" reduction in salary and incentives from its board and executive committee. Also, IHG will pull its final dividend of 85.9 US cents - saving about USD150 million - and said it will delay any further dividends until "visibility has improved". The hotel owner will also delay renovations and relax brand standards. Turning to trading, IHG said its global revenue per available room was down 6% in January and February, with a flat performance in the US being offset by a catastrophic drop in Greater China. In February, RevPAR in Greater China was down 90% year on year.

----------

Carnival, up 5.2%. The cruise operator said revenue for the first quarter increased 2.1% to USD4.8 billion from USD4.7 billion a year ago. However, Carnival swung to a first-quarter loss, with earnings dented by disruption due to the early days of the current Covid-19 pandemic. The company recorded a GAAP net loss of USD781 million, or USD1.14 per share, for the quarter ended February 29. This compares to net income of USD336 million, or earnings per share of USD0.48, for the first quarter a year ago. The impact of Covid-19 on the first quarter's net loss was around USD0.23 per share, the firm said, taking into account cancelled voyages and disruptions. Carnival said Covid-19 will have a "material negative impact" on its financial results and liquidity.

----------

FTSE 250 - WINNERS

----------

Future, up 30%. The media company said declines in its travel magazine portfolio have been offset by its grocery titles, resulting in "strong" digital audience numbers. "The period started well with exceptionally strong digital audience numbers with the resultant beneficial flow through to eCommerce and digital advertising," Future said. As a result, the company expects its results for the six months to the end of March to be in line with internal expectations. "The recent weeks have been unprecedented. However, our business has continued to trade robustly, with the diversified strategy working well. As of today, we have seen limited impact on our digital revenues," Future said. Despite the "robust" trading, Future said it is implementing some profit protection measures.

----------

JD Wetherspoon, up 27%. The pub chain operator reported a rise in profit and revenue in the first half of its financial year, but has cancelled its dividend due to the uncertainty surrounding the Covid-19 outbreak. In the 26 weeks to January 26, Wetherspoon's recorded pretax profit of GBP57.9 million, up 15% from the GBP50.3 million seen in the same period the year before. Revenue was 4.9% higher year-on-year at GBP933.0 million from GBP889.6 million. Like-for-like sales in the first half of the financial year were 5.0% higher. Like-for-like bar sales increased by 4.2%, food sales by 5.6% and fruit/slot machines by 20%. Like-for-like hotel room sales decreased by 1.3%, however. Bar sales were 60% of total sales, Wetherspoons noted. Despite the strong performance, the bar owner has cancelled its interim dividend - owing to the uncertainty caused by the spread of Covid-19.

----------

FTSE 250 - LOSERS

----------

Inchcape, down 3.1%. The automotive retailer said it will suspend its share buyback programme due to uncertainty arising from the Covid-19 outbreak. Inchcape has completed around GBP25 million of the GBP150 million repurchase programme but will serve notice to its brokers to terminate the buyback effective from next Tuesday. "Inchcape has a strong balance sheet and remains committed to its disciplined capital allocation policy, but the board believes this is the right decision at this time," the company said. As at the end of 2019, the company had cash of GBP423.0 million with total assets valued at GBP4.46 billion.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Faron Pharma, up 16%. The Finnish drug discovery company said its assets increased to EUR1.6 million in 2019 compared to just EUR400,000 reported a year earlier. As at December 31, the company said it had cash balances of EUR7.1 million compared to EUR4.1 million the year before. As a result, pretax loss narrowed to EUR13.3 million from EUR20.1 million year-on-year. The company did not generate any revenue during the year as it is currently focused on the development of Clevegen, a novel cancer immunotherapy.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Christie Group, down 5.5%. The financial services provider said it expects its 2019 results to be in line with expectations. The company said it has benefited from the profitable sale of an office building, as mentioned in our Interim results statement. However, Christie noted that its business - which operate in the hospitality, retail, medical and educational fields - took a hit from the Covid-19. This is primarily as a result of having limited access to certain of its clients' premises. "It is not currently possible to quantify the full effect of Covid-19 related disruption on our business for 2020 or beyond," said Christie in its statement Friday.

----------

Tracsis, down 1.7%. The traffic data provider said it is not possible to accurately quantify the impact on the second-half trading and therefore full year expectations amid rapidly changing situation with coronavirus. Tracsis said it expects the Rail Technology & Services division to have resilience as it derives most of its income from highly recurring product sales. However, parts of the Traffic & Data Services division are forecast to be hurt by Covid-19. In particular, the company's events businesses SEP and CTM both derive a significant amount of revenue from major UK based outdoor events, and in recent days Tracsis said it has been notified by some major clients that events scheduled for this summer will either be cancelled or postponed to the autumn. Tracsis said it expects further events to be cancelled or postponed in due course.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2023 14:21

Faron Pharmaceuticals test data shows efficacy of bexmarilimab

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.

Read more
17 Apr 2023 16:34

TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
29 Mar 2023 10:42

Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O'Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.

Read more
29 Mar 2023 09:38

Faron Pharmaceuticals names James O'Brien as CFO

(Sharecast News) - Drug discovery and development company Faron Pharmaceuticals has tapped James O'Brien to take over as its new chief financial officer.

Read more
22 Mar 2023 17:12

Faron Pharmaceuticals gets positive feedback from FDA meeting

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.

Read more
17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

Monday 20 March 
Aukett Swanke Group PLCGM re proposed acquisition of Torpedo Factory Group Ltd
Pantheon Resources PLCAGM
Voyager Life PLCGM re subscription and fundraise
Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
Zaim Credit Systems PLCGM re director removal and name change
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Mar 2023 11:53

Faron Pharmaceuticals annual loss widens on higher research costs

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts.

Read more
24 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Monday 27 February 
Associated British Foods PLCTrading Statement
Beeks Financial Cloud Group PLCHalf Year Results
Bunzl PLCFull Year Results
Centralnic Group PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
DX Group PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Kosmos Energy LtdFull Year Results
Quartix Technologies PLCFull Year Results
RHI Magnesita NVFull Year Results
Senior PLCFull Year Results
Tuesday 28 February 
abrdn PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Bluefield Solar Income Fund LtdHalf Year Results
boohoo Group PLCFull Year Results
Cap-XX LtdHalf Year Results
Croda International PLCFull Year Results
Dalata Hotel Group PLCFull Year Results
Derwent London PLCFull Year Results
Hutchmed (China) LtdFull Year Results
Intertek Group PLCFull Year Results
Kitwave Group PLCFull Year Results
Man Group PLCFull Year Results
McBride PLCHalf Year Results
Morgan Advanced Materials PLCFull Year Results
Ocado Group PLCFull Year Results
Princess Private Equity Holding LtdFull Year Results
Rotork PLCFull Year Results
Serco Group PLCFull Year Results
St James's Place PLCFull Year Results
S-Ventures PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Videndum PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 1 March 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
GetBusy PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Global Invacom Group LtdFull Year Results
Haydale Graphene Industries PLCHalf Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
Permanent TSB Group Holdings PLCFull Year Results
Persimmon PLCFull Year Results
Rathbones Group PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Ricardo PLCHalf Year Results
Weir Group PLCFull Year Results
Thursday 2 March 
Alfa Financial Software Holdings PLCFull Year Results
Apax Global Alpha LtdFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Cairn Homes PLCFull Year Results
Capita PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Grafton Group PLCFull Year Results
Haleon PLCFull Year Results
Hunting PLCFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Metro Bank PLCFull Year Results
National Express Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder AsiaPacific Fund PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Friday 3 March 
Avation PLCHalf Year Results
Faron Pharmaceuticals LtdFull Year Results
IMI PLCFull Year Results
Pacific Horizon Investment Trust PLCHalf Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
27 Jan 2023 18:56

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Jan 2023 10:28

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023.

Read more
27 Jan 2023 10:11

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jan 2023 16:26

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 12:06

Faron Pharmaceuticals sees patient remission in immunotherapy trials

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function.

Read more
1 Dec 2022 21:42

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Nov 2022 19:49

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.